Skip to main content
. 2024 Jan 2;24:71. doi: 10.1186/s12889-023-17568-6

Table 1.

Relative change in the monthly rate of healthcare utilization related to chronic diseases before and during the COVID-19 pandemic

Outcome Utilization rate before the COVID-19 pandemic
Mean (SD)
Utilization rate during COVID-19 pandemic
Mean (SD)
Relative Change in utilization rates before and during COVID-19 pandemice
Hospital Outpatient Hospital Inpatient PHC Outpatient Hospital Outpatient Hospital Inpatient PHC Outpatient Hospital Outpatient Hospital Inpatient PHC Outpatient
Overall rate at national levela 286.90 (67.43) 31.47 (3.36) 499.99 (15.95) 243.77 (38.56) 20.56 (4.05) 539.35 (75.68) -15.03% -34.67% 7.8%
Overall rate across different Regionsb
     Region 1 338.50 (78.68) 31.96 (3.56) 562.36 (174.43) 287.09 (43.15) 21.39 (4.65) 604.12 (85.22) -15.19% -33.07% 7.43%
     Region 2 287.07 (64.62) 28.57 (4.13) 504.50 (153.15) 238.16 (40.60) 19.40 (3.42) 536.22 (74.00) -17.04% -32.10% 6.29%
     Region 3 195.11 (54.25) 34.81 (4.13) 430.63 (155.79) 174.13 (33.99) 21.11 (4.14) 477.68 (66.45) -10.75% -39.36% 10.93%
     Region 4 240.52 (60.80) 32.37 (4.96) 382.76 (137.97) 202.98 (36.08) 19.32 (4.22) 401.09 (62.94) -15.61% -40.32% 4.79%
     Region 5 94.01 (15.37) 19.55 (3.13) 140.86 (46.54) 76.05 (12.75) 13.21 (3.20) 172.89 (26.68) -19.10% -32.43% 22.74%
Rates among chronic disease patients across diagnosis groupsc
     (1) No CVDs, but with single chronic morbidity 102.22 (24.51) 12.28 (1.27) 314.53 (98.86) 76.83 (15.42) 7.89 (1.51) 325.75 (51.15) -24.84% -35.75% 3.57%
     (2) No CVDs, but with multimorbidity 61.94 (10.88) 7.62 (0.81) 89.56 (20.02) 47.70 (7.23) 4.73 (0.88) 84.65 (10.51) -22.99% -37.93% -5.48%
     (3) CVDs, but no comorbidity 21.69 (5.29) 2.63 (0.40) 23.69 (11.11) 16.39 (2.81) 1.54 (0.32) 30.73 (4.00) -24.44% -41.44% 29.72%
     (4) CVDs and one comorbidity 37.93 (12.48) 3.56 (0.61) 32.33 (14.77) 38.54 (5.76) 2.58 (0.76) 44.64 (5.19) 1.61% -27.53% 38.08%
     (5) CVDs and multimorbidity 63.10 (16.84) 5.36 (1.04) 39.87 (16.34) 64.28 (8.03) 3.79 (0.76) 53.56 (5.61) 1.87% -29.29% 34.34%
Rates among patients with CVDs and multimorbidity across regionsd
     Region 1 77.72 (18.87) 5.88 (1.08) 44.87 (18.06) 77.70 (9.40) 3.97 (0.81) 60.94 (6.10) -0.03% -32.48% 35.81%
     Region 2 59.55 (18.11) 4.57 (1.37) 43.58 (17.93) 60.73 (8.09) 3.86 (1.15) 57.27 (6.86) 1.98% -15.54% 31.41%
     Region 3 36.75 (14.78) 4.95 (1.39) 32.36 (14.03) 44.25 (6.06) 3.77 (0.88) 43.61 (5.65) 20.41% -23.84% 34.77%
     Region 4 51.77 (17.49) 5.45 (2.09) 31.09 (15.27) 43.93 (7.46) 3.33 (0.75) 35.35 (3.37) -15.14% -38.90% 13.70%
     Region 5 17.41 (6.63) 2.85 (1.28)

9.71

(5.02)

17.49 (3.60) 2.09 (1.05) 14.57 (2.12) 0.46% -26.67% 50.05%

The monthly rate was presented per 10,000 NHI members

aNumerator was the number of visits with chronic diseases (overall group). The denominator was the number of NHI members at the national level. PHC = Primary Healthcare

bNumerator was the number of visits with chronic diseases (overall group). The denominator was the number of NHI members at the regional level

cNumerator was the number of visits with chronic diseases in each group. The denominator was the number of NHI members at the national level

dThe numerator was the number of visits by NHI members with CVDs and multimorbidity per region, and the denominator was the total NHI member population per region. See Supplementary Figure S2 for details about the regions

e RelativeChange=visitratesduringCOVID-19-visitratesbeforeCOVID-19visitratesbeforeCOVID-19